Essential cookies only by default. Analytics and error replays need your OK.
Nicotinamide Riboside (NR)
A vitamin B3 precursor that reliably raises cellular NAD+ levels and is well tolerated — but human trials have so far shown mostly null or mixed results on the functional outcomes (muscle, metabolism, blood pressure, cognition) that elevation is meant to drive.
What the evidence says
Nicotinamide Riboside doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 2018–2026 with a typical study size of 90 participants.
Based on 47 studies · 3 meta-analyses · 30 RCTs · 14,906 total participants
Study base
Strong study baseBy outcome
Every outcome below: Too few graded studies.
Multiple RCTs robustly and dose-dependently raise blood NAD+ with strong safety, but most human functional endpoints (muscle, insulin sensitivity, mitochondrial respiration, blood pressure, cognition) are null or mixed, holding it to Moderate.
53 trials ongoing or recruiting · 56 completed on ClinicalTrials.gov
14 of the completed trials have posted results
Registered trials show research momentum for Nicotinamide Riboside, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Nicotinamide Riboside (NR) is a naturally occurring form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme used in hundreds of metabolic reactions. NAD+ levels decline with age, and NR reliably and dose-dependently raises whole-blood NAD+ in humans (by about 142% at 1,000 mg a day).
Unlike niacin it does not cause flushing.
Raising blood NAD+ is a biomarker, not a clinical outcome, and the human trials to date are largely disappointing on function: a meta-analysis found no benefit for muscle mass or strength in older adults, RCTs found no improvement in insulin sensitivity, aerobic capacity or skeletal-muscle mitochondria (muscle NAD+ itself did not rise in a 12-week trial), a hypertension trial missed its primary endpoint, and cognition did not change in a pilot trial in mild cognitive impairment.
The positive signals are few and small: lower sputum IL-8 in a COPD trial, lower circulating cytokines in small trials, a modest walking-distance gain in peripheral artery disease, and a variable rise in brain NAD in early Parkinson's disease.
Preclinical data are striking, but everyday energy, longevity and cognitive benefits in healthy people remain unproven.
NR is converted to NAD+ and reliably raises NAD+ in blood. In muscle it raises NAD+ metabolites, although steady-state muscle NAD+ did not change in a 12-week trial, and in Parkinson's disease it raised brain NAD levels variably.
In cell and animal studies, higher NAD+ activates sirtuins (SIRT1-7), NAD+-dependent deacetylases that regulate mitochondrial biogenesis, DNA repair and inflammatory gene expression. This has not been shown to translate into clinical benefit in humans.
In animal studies NR supports mitochondrial function by restoring NAD+/NADH ratios. Human muscle trials have not confirmed this: mitochondrial respiration, content and morphology were unchanged, and one trial found mitochondrial gene pathways downregulated.
Raising NAD+ dampens NF-kB-driven inflammatory pathways in preclinical models. In small human trials NR lowered some circulating cytokines, including in blood and cerebrospinal fluid in Parkinson's disease, and lowered sputum IL-8 in COPD.
NAD+ is an essential substrate for PARP enzymes that detect and repair DNA strand breaks, protecting genomic stability in aging cells.
How Nicotinamide Riboside works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Showing the best-supported pathways — 3 lower-evidence nodes hidden for clarity.
Insufficient safety data in human pregnancy; avoid unless directed by a physician. Animal studies suggest NR may be important for embryonic development but human data are lacking.
Insufficient data; avoid or consult healthcare provider before use.
No clinical data available in pediatric populations outside of specific disease states (e.g., ataxia telangiectasia). Not recommended for general use without medical supervision.
Generally well-tolerated; multiple RCTs conducted in this population. May be particularly beneficial given age-related NAD+ decline. Start with lower doses (250 mg/day) and titrate.
Consult oncologist before use. Theoretical concern about NAD+ supporting tumor cell metabolism; some evidence suggesting context-dependent effects.
Some clinical trials have been conducted in CKD; generally tolerated but monitor renal function. Consult nephrologist. High-dose supplementation may accumulate metabolites.
Use with caution at higher doses; monitor liver enzymes. Lower doses (≤300 mg/day) appear safe based on available data.
Unverified mechanistic concern: NAD+ is required for DNA repair, so raising NAD+ could in theory reduce the efficacy of DNA-damaging chemotherapy. No human study has measured this. Consult the oncologist before use.
Unverified mechanistic concern: NR increases the NAD+ substrate available to PARP enzymes, which could in theory work against PARP inhibitors. No human study has measured this. Consult the oncologist before use.
Chronic alcohol consumption depletes NAD+ and may counteract NR supplementation benefits.
Isoniazid inhibits NAD+ biosynthesis; NR may counteract drug-induced NAD+ depletion — generally a beneficial interaction but may affect drug monitoring.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: If you develop a new or unexpected symptom, pause this optional product and seek advice before trying a lower dose, a different schedule or an added remedy. Follow any urgent instructions for the symptom now.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: Usually transient; ensure adequate hydration
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: If you develop a new or unexpected symptom, pause this optional product and seek advice before trying a lower dose, a different schedule or an added remedy. Follow any urgent instructions for the symptom now.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: NR very rarely causes flushing unlike niacin; if it occurs, rule out other causes
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: Usually transient during first weeks; may resolve with continued use
Tip: No generally safe long-term supplemental dose is established here for nicotinamide riboside. Persistent symptoms or use alongside medicines need clinical review; liver testing does not make an unreviewed regimen safe.
Nicotinamide Riboside has an evidence score of 5.5/10 — moderate evidence based on 47 indexed studies, including 2 meta-analyses. A vitamin B3 precursor that reliably raises cellular NAD+ levels and is well tolerated — but human trials have so far shown mostly null or mixed results on the functional outcomes (muscle, metabolism, blood pressure, cognition) that elevation is meant to drive. Representative study: PMID 40275690.
The best time to take Nicotinamide Riboside is in the morning. Taking it with food is preferred. Taking NR in the morning aligns with circadian NAD+ biosynthesis rhythms and avoids potential sleep disruption from increased cellular energy metabolism.
Nicotinamide Riboside is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects include elevated liver enzymes at very high doses (a precaution, not reported in the cited trials), nausea, headache. How often they occur is not established for all of them. Use caution if any of these apply to you: Known hypersensitivity to nicotinamide riboside or niacin derivatives; Active cancer or cancer history: NAD+ elevation may theoretically support tumor cell metabolism (consult oncologist before use); Severe hepatic impairment: high-dose NAD+ precursors may affect liver metabolism.
CoQ10
HelpedA lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.
Berberine
HelpedActivates AMPK to regulate blood sugar, improve insulin sensitivity, and support lipid metabolism. Its only head-to-head trial with metformin cited here was a 36-person pilot, which does not show it can replace metformin.
Huperzine A
Too few graded studiesAcetylcholinesterase inhibitor from club moss, studied mainly for Alzheimer's and dementia; cognitive evidence is mixed and limited by trial quality.
Phosphatidylserine
Too few graded studiesKey brain membrane phospholipid that facilitates neurotransmitter release, memory formation, and post-exercise cortisol reduction.
Explore: Best supplements for Vitality & LongevityBest supplements for Athletic PerformanceBest supplements for Focus, Memory & Mood
Reviewed by Dr. Baher Al Hakim · Last reviewed May 2026 · evidence from 47 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research